menu
    • menu

    Company profile for Vesigen Therapeutics

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Vesigen is developing groundbreaking therapeutic products directed to intracellular targets using a scalable and extracellular vesicle delivery technology. Our patented technology, called ARMMs (ARRDC1 Mediated Microvesicles), enables us to deliver a wide range of payloads, including RNAs (mRNA, shRNA, ribozymes), proteins (signaling proteins, enzymes, antibody fragments), and editing complexes (Cas9/gRNA) directly into the cy...
    Vesigen is developing groundbreaking therapeutic products directed to intracellular targets using a scalable and extracellular vesicle delivery technology. Our patented technology, called ARMMs (ARRDC1 Mediated Microvesicles), enables us to deliver a wide range of payloads, including RNAs (mRNA, shRNA, ribozymes), proteins (signaling proteins, enzymes, antibody fragments), and editing complexes (Cas9/gRNA) directly into the cytoplasm of target cells, expanding the universe of druggable targets. Our team is committed to leveraging ARMMs technology to enable new therapies and address currently unmet medical needs.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Vesigen TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    One Kendall Square Building 200, Suite 001 Cambridge, MA 02139
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.vesigentx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/vesigen-therapeutics/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/vesigen_tx

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Turn Biotechnologies Acquires ARMMs Vesicular Technology
    Turn Biotechnologies Acquires ARMMs Vesicular Technology

    26 Mar 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/turn-biotechnologies-acquires-armms-vesicular-technology-to-increase-access-to-tissue-targets-for-its-epigenetic-reprogramming-therapies-302411491.html

    PR NEWSWIRE
    26 Mar 2025
    Share Share
    Vesigen Highlights Non-Viral Delivery Platform Data At ASGCT, ARVO 2024
    Vesigen Highlights Non-Viral Delivery Platform Data At ASGCT, ARVO 2024

    13 May 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240513132852/en

    BUSINESSWIRE
    13 May 2024
    Share Share
    Vesigen: ARMM Ophthalmology Data At ARVO 2024
    Vesigen: ARMM Ophthalmology Data At ARVO 2024

    01 May 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240501521043/en

    BUSINESSWIRE
    01 May 2024
    Share Share
    Vesigen Presenting Engineered ARMMs Tech At ASGCT 2024
    Vesigen Presenting Engineered ARMMs Tech At ASGCT 2024

    22 Apr 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240422649099/en

    BUSINESSWIRE
    22 Apr 2024
    Share Share
    Vesigen to Present at the 2024 Cell and Gene Meeting on the Med
    Vesigen to Present at the 2024 Cell and Gene Meeting on the Med

    03 Apr 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240403820339/en

    BUSINESSWIRE
    03 Apr 2024
    Share Share
    Vesigen Highlights Non-Human Primate Biodistribution of Non-Viral Technology
    Vesigen Highlights Non-Human Primate Biodistribution of Non-Viral Technology

    19 Oct 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231019250423/en

    BUSINESSWIRE
    19 Oct 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search